Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-020564
Filing Date
2024-05-20
Accepted
2024-05-20 09:46:09
Documents
50
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 509926
2 ex31-1.htm EX-31.1 19282
3 ex31-2.htm EX-31.2 19302
4 ex32-1.htm EX-32.1 7568
5 ex32-2.htm EX-32.2 7705
  Complete submission text file 0001493152-24-020564.txt   3162511

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE rtgn-20240331.xsd EX-101.SCH 24621
7 XBRL CALCULATION FILE rtgn-20240331_cal.xml EX-101.CAL 26956
8 XBRL DEFINITION FILE rtgn-20240331_def.xml EX-101.DEF 125047
9 XBRL LABEL FILE rtgn-20240331_lab.xml EX-101.LAB 230729
10 XBRL PRESENTATION FILE rtgn-20240331_pre.xml EX-101.PRE 190951
53 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 358760
Mailing Address 1450 NORTH MCDOWELL BOULEVARD SUITE 150 PETALUMA CA 94954
Business Address 1450 NORTH MCDOWELL BOULEVARD SUITE 150 PETALUMA CA 94954 415-578-9583
RetinalGenix Technologies Inc. (Filer) CIK: 0001836295 (see all company filings)

EIN.: 823936890 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-258528 | Film No.: 24962772
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)